Preferential	O
transcription	O
of	O
HTLV-I	B-DNA
LTR	I-DNA
in	O
cell-free	O
extracts	O
of	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
producing	O
HTLV-I	B-protein
viral	I-protein
proteins	I-protein
.	O

The	O
promoters	B-DNA
of	O
the	O
adenovirus	B-DNA
2	I-DNA
major	I-DNA
late	I-DNA
gene	I-DNA
,	O
the	O
mouse	B-DNA
beta-globin	I-DNA
gene	I-DNA
,	O
the	O
mouse	B-DNA
immunoglobulin	I-DNA
VH	I-DNA
gene	I-DNA
and	O
the	O
LTR	B-DNA
of	O
the	O
human	O
T-lymphotropic	O
retrovirus	O
type	O
I	O
were	O
tested	O
for	O
their	O
transcription	O
activities	O
in	O
cell-free	O
extracts	O
of	O
four	O
cell	O
lines	O
;	O
HeLa	B-cell_line
,	O
CESS	B-cell_line
(	O
Epstein-Barr	B-cell_line
virus-transformed	I-cell_line
human	I-cell_line
B	I-cell_line
cell	I-cell_line
line	I-cell_line
)	O
,	O
MT-1	B-cell_line
(	O
HTLV-I-infected	B-cell_line
human	I-cell_line
T	I-cell_line
cell	I-cell_line
line	I-cell_line
without	O
viral	O
protein	O
synthesis	O
)	O
,	O
and	O
MT-2	B-cell_line
(	O
HTLV-I-infected	B-cell_line
human	I-cell_line
T	I-cell_line
cell	I-cell_line
line	I-cell_line
producing	O
viral	B-protein
proteins	I-protein
)	O
.	O

LTR	B-DNA
was	O
preferentially	O
transcribed	O
in	O
the	O
extracts	O
of	O
MT-2	B-cell_line
although	O
the	O
other	O
three	O
genes	O
were	O
transcribed	O
with	O
relatively	O
constant	O
efficiencies	O
in	O
different	O
extracts	O
.	O

The	O
results	O
agree	O
well	O
with	O
the	O
previous	O
in	O
vivo	O
studies	O
on	O
the	O
promoter	O
activity	O
of	O
HTLV-I	B-DNA
LTR	I-DNA
.	O

Mixing	O
of	O
HeLa	O
and	O
MT-2	O
extracts	O
revealed	O
the	O
presence	O
of	O
a	O
LTR-specific	O
stimulating	O
activity	O
in	O
MT-2	O
extracts	O
.	O

Volume	NULL
14	NULL
Number	NULL
12	NULL
1986	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
Preferential	NULL
transcription	NULL
of	NULL
HTLV-I	NULL
LTR	NULL
in	NULL
cell-free	NULL
extracts	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
producing	NULL
HTLV-I	NULL
viral	NULL
proteins	NULL
Norisada	NULL
Matsunami	NULL
,	NULL
Haruhiko	NULL
Siomi*	NULL
,	NULL
Masakazu	NULL
Hatanaka+	NULL
,	NULL
Yoshio	NULL
Yaoita	NULL
and	NULL
Tasuku	NULL
Honjo	NULL
Department	NULL
of	NULL
Medical	NULL
Chemistry	NULL
,	NULL
Kyoto	NULL
University	NULL
Faculty	NULL
of	NULL
Medicine	NULL
and	NULL
*Department	NULL
of	NULL
Serology	NULL
and	NULL
Immunology	NULL
,	NULL
Institute	NULL
for	NULL
Virus	NULL
Research	NULL
,	NULL
Kyoto	NULL
University	NULL
,	NULL
Sakyo-ku	NULL
,	NULL
Kyoto	NULL
606	NULL
,	NULL
Japan	NULL
Received	NULL
16	NULL
April	NULL
1986	NULL
;	NULL
Accepted	NULL
16	NULL
May	NULL
1986	NULL
ABSTRACT	NULL
The	NULL
promoters	NULL
of	NULL
the	NULL
adenovirus	NULL
2	NULL
major	NULL
late	NULL
gene	NULL
,	NULL
the	NULL
mouse	NULL
gene	NULL
,	NULL
the	NULL
mouse	NULL
immunoglobulin	NULL
VH	NULL
gene	NULL
and	NULL
the	NULL
LTR	NULL
of	NULL
the	NULL
human	NULL
T-lympho-	NULL
_	NULL
tropic	NULL
retrovirus	NULL
type	NULL
I	NULL
were	NULL
tested	NULL
for	NULL
their	NULL
transcription	NULL
activities	NULL
in	NULL
cell-free	NULL
extracts	NULL
of	NULL
four	NULL
cell	NULL
lines	NULL
;	NULL
HeLa	NULL
,	NULL
CESS	NULL
(	NULL
Epstein-Barr	NULL
virus-transformed	NULL
human	NULL
B	NULL
cell	NULL
line	NULL
)	NULL
,	NULL
MT-1	NULL
(	NULL
HTLV-I-infected	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
without	NULL
viral	NULL
protein	NULL
synthesis	NULL
)	NULL
,	NULL
and	NULL
MT-2	NULL
(	NULL
HTLV-I-infected	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
producing	NULL
viral	NULL
proteins	NULL
)	NULL
.	NULL

LTR	NULL
was	NULL
preferentially	NULL
transcribed	NULL
in	NULL
the	NULL
extracts	NULL
of	NULL
MT-2	NULL
although	NULL
the	NULL
other	NULL
three	NULL
genes	NULL
were	NULL
transcribed	NULL
with	NULL
relatively	NULL
constant	NULL
efficiencies	NULL
in	NULL
different	NULL
extracts	NULL
.	NULL

The	NULL
results	NULL
agree	NULL
well	NULL
with	NULL
the	NULL
previous	NULL
in	NULL
vivo	NULL
studies	NULL
on	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
HTLV-I	NULL
LTR	NULL
.	NULL

Mixing	NULL
of	NULL
HeLa	NULL
and	NULL
MT-2	NULL
extracts	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
LTR-specific	NULL
stimulating	NULL
activity	NULL
in	NULL
MT-2	NULL
extracts	NULL
.	NULL

INTRODUCTION	NULL
Human	NULL
T-lymphotropic	NULL
retrovirus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I/ATLV	NULL
)	NULL
is	NULL
an	NULL
etiologic-al	NULL
agent	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
which	NULL
is	NULL
a	NULL
unique	NULL
malignancy	NULL
of	NULL
a	NULL
helper	NULL
subset	NULL
of	NULL
T-cells	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

HTLV-I	NULL
,	NULL
HTLV	NULL
type	NULL
II	NULL
(	NULL
HTLV-II	NULL
)	NULL
,	NULL
and	NULL
bovine	NULL
leukemia	NULL
virus	NULL
(	NULL
BLV	NULL
)	NULL
share	NULL
common	NULL
structural	NULL
and	NULL
biological	NULL
fea-tures	NULL
,	NULL
comprising	NULL
a	NULL
family	NULL
(	NULL
HTLV-BLV	NULL
)	NULL
of	NULL
transforming	NULL
retroviruses	NULL
.	NULL

The	NULL
genomes	NULL
of	NULL
these	NULL
viruses	NULL
do	NULL
not	NULL
contain	NULL
typical	NULL
one	NULL
genes	NULL
and	NULL
do	NULL
not	NULL
seem	NULL
to	NULL
activate	NULL
cellular	NULL
one	NULL
genes	NULL
by	NULL
promoter	NULL
insertion	NULL
(	NULL
4	NULL
)	NULL
.	NULL

They	NULL
are	NULL
structurally	NULL
unique	NULL
among	NULL
retroviruses	NULL
in	NULL
possessing	NULL
extra	NULL
sequences	NULL
called	NULL
``	NULL
px	NULL
``	NULL
cal	NULL
of	NULL
nonacute	NULL
leukemia	NULL
viruses	NULL
(	NULL
4,5	NULL
)	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
viral	NULL
long	NULL
in	NULL
the	NULL
virus	NULL
genome	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
gag	NULL
,	NULL
pol	NULL
,	NULL
and	NULL
env	NULL
genes	NULL
typi-	NULL
terminal	NULL
repeats	NULL
(	NULL
LTR	NULL
)	NULL
of	NULL
these	NULL
viruses	NULL
seems	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
transacting	NULL
factors	NULL
in	NULL
infected	NULL
cells	NULL
(	NULL
6-10	NULL
)	NULL
.	NULL

Studies	NULL
on	NULL
the	NULL
mechanism	NULL
of	NULL
trans-activation	NULL
of	NULL
LTR	NULL
is	NULL
important	NULL
for	NULL
understanding	NULL
not	NULL
only	NULL
the	NULL
regulatory	NULL
mechanism	NULL
of	NULL
tissue-specific	NULL
gene	NULL
expression	NULL
but	NULL
also	NULL
the	NULL
molecular	NULL
mechanism	NULL
of	NULL
leukemogenesis	NULL
by	NULL
the	NULL
T-lymphotropic	NULL
retroviruses	NULL
.	NULL

Recent	NULL
DNA	NULL
transfection	NULL
experiments	NULL
by	NULL
several	NULL
groups	NULL
suggested	NULL
direct	NULL
or	NULL
indirect	NULL
involvement	NULL
of	NULL
a	NULL
pX	NULL
gene	NULL
product	NULL
in	NULL
©	NULL
IRL	NULL
Press	NULL
Limited	NULL
,	NULL
Oxford	NULL
,	NULL
England	NULL
.	NULL

4779	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
the	NULL
trans-acting	NULL
transcriptional	NULL
activation	NULL
of	NULL
HTLV-LTR	NULL
(	NULL
6	NULL
,	NULL
10-12	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mode	NULL
of	NULL
the	NULL
activation	NULL
is	NULL
unknown	NULL
;	NULL
it	NULL
is	NULL
unclear	NULL
whether	NULL
the	NULL
pX	NULL
product	NULL
activates	NULL
transcription	NULL
directly	NULL
by	NULL
recognizing	NULL
the	NULL
LTR	NULL
sequences	NULL
or	NULL
indirectly	NULL
by	NULL
modifying	NULL
other	NULL
cellular	NULL
components	NULL
.	NULL

Since	NULL
the	NULL
in	NULL
vivo	NULL
assay	NULL
system	NULL
using	NULL
DNA	NULL
transfection	NULL
is	NULL
not	NULL
suitable	NULL
for	NULL
elucidating	NULL
the	NULL
detailed	NULL
molecular	NULL
mechanism	NULL
of	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
viral	NULL
LTR	NULL
,	NULL
we	NULL
reconstituted	NULL
a	NULL
cell-free	NULL
system	NULL
which	NULL
allowed	NULL
cell-specific	NULL
transcription	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
promoter	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-transformed	NULL
human	NULL
B-cell	NULL
line	NULL
CESS	NULL
(	NULL
14	NULL
,	NULL
P.	NULL
Ralph	NULL
)	NULL
and	NULL
HTLV-I	NULL
infected	NULL
human	NULL
leukemic	NULL
T-cell	NULL
lines	NULL
,	NULL
MT-l	NULL
(	NULL
15	NULL
)	NULL
and	NULL
MT-2	NULL
(	NULL
16	NULL
)	NULL
,	NULL
were	NULL
grown	NULL
in	NULL
RPMIl640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
suspension	NULL
culture	NULL
in	NULL
Eagle	NULL
's	NULL
minimal	NULL
essential	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Preparation	NULL
of	NULL
whole	NULL
cell	NULL
transcription	NULL
extracts	NULL
from	NULL
these	NULL
cell	NULL
lines	NULL
and	NULL
in	NULL
vitro	NULL
transcription	NULL
in	NULL
these	NULL
extracts	NULL
were	NULL
carried	NULL
out	NULL
according	NULL
to	NULL
the	NULL
procedure	NULL
of	NULL
Manley	NULL
et	NULL
al	NULL
.	NULL

(	NULL
17	NULL
)	NULL
.	NULL

A	NULL
standard	NULL
transcription	NULL
reaction	NULL
mixture	NULL
(	NULL
25	NULL
ul	NULL
)	NULL
contained	NULL
;	NULL
12	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
7.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
60	NULL
mM	NULL
KCl	NULL
,	NULL
60	NULL
pM	NULL
EDTA	NULL
,	NULL
1.2	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
,	NULL
10	NULL
mM	NULL
creatine	NULL
phosphate	NULL
,	NULL
500	NULL
yM	NULL
each	NULL
of	NULL
unlabeled	NULL
nucleotide	NULL
triphosphates	NULL
(	NULL
ATP	NULL
,	NULL
CTP	NULL
and	NULL
UTP	NULL
)	NULL
,	NULL
50	NULL
uM	NULL
[	NULL
a-32P1GTP	NULL
(	NULL
10	NULL
uCi	NULL
)	NULL
,	NULL
200	NULL
ug	NULL
of	NULL
whole	NULL
cell	NULL
extracts	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
cleaved	NULL
plasmid	NULL
DNA	NULL
(	NULL
optimum	NULL
concentration	NULL
)	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
at	NULL
30°C	NULL
for	NULL
60	NULL
min	NULL
.	NULL

Reactions	NULL
were	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
150	NULL
ul	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
Sarkosy1l	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
100	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
EDTA	NULL
and	NULL
40	NULL
ug	NULL
tRNA	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
extracted	NULL
with	NULL
phenol	NULL
and	NULL
chloroform/isoamyl-alcohol	NULL
(	NULL
24:1	NULL
)	NULL
and	NULL
the	NULL
extracts	NULL
were	NULL
precipitated	NULL
by	NULL
ethanol	NULL
.	NULL

RNAs	NULL
were	NULL
electrophoresed	NULL
in	NULL
5	NULL
%	NULL
polyacrylamide/7	NULL
M	NULL
urea	NULL
gel	NULL
at	NULL
50	NULL
volt/cm	NULL
and	NULL
the	NULL
dried	NULL
gels	NULL
were	NULL
autoradiographed	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Construction	NULL
of	NULL
template	NULL
DNA	NULL
Template	NULL
plasmids	NULL
were	NULL
constructed	NULL
so	NULL
that	NULL
the	NULL
lengths	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
run-off	NULL
products	NULL
were	NULL
between	NULL
300	NULL
and	NULL
600	NULL
bases	NULL
.	NULL

Their	NULL
structures	NULL
are	NULL
schematically	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Plasmid	NULL
pU3RUS	NULL
contains	NULL
HTLV-I	NULL
LTR	NULL
fragment	NULL
consisting	NULL
of	NULL
the	NULL
U3	NULL
,	NULL
R	NULL
,	NULL
and	NULL
US	NULL
(	NULL
5	NULL
'	NULL
half	NULL
)	NULL
sequences	NULL
in	NULL
a	NULL
pUCl9	NULL
vector	NULL
.	NULL

We	NULL
used	NULL
HindIII-cleaved	NULL
pU3RUS	NULL
as	NULL
a	NULL
truncated	NULL
template	NULL
which	NULL
was	NULL
expected	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
a	NULL
run-off	NULL
product	NULL
of	NULL
330	NULL
bases	NULL
upon	NULL
the	NULL
faithful	NULL
4780	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
Smal	NULL
HindIII	NULL
(	NULL
RsaI	NULL
)	NULL
|	NULL
us	NULL
J	NULL
_r	NULL
_|	NULL
us	NULL
|	NULL
hove	NULL
2	NULL
\\\\\	NULL
F	NULL
~~~~~~~	NULL
§	NULL
?	NULL

a1	NULL
330b	NULL
//	NULL
BamHI/Bg1II	NULL
A	NULL
2	NULL
C	NULL
\	NULL
,	NULL
540b	NULL
HindIII®	NULL
PstI	NULL
HindIII®*	NULL
pucis	NULL
pucls	NULL
HindIII	NULL
B	NULL
70h	NULL
D	NULL
560b	NULL
BanHI®	NULL
pAd2	NULL
SmaI-F	NULL
SmaI®	NULL
pucis	NULL
pBR31L3	NULL
SmaI*	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
plasmids	NULL
used	NULL
as	NULL
templates	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
.	NULL

(	NULL
A	NULL
)	NULL
pU3RU5S	NULL
;	NULL
HTLV-I	NULL
LTR	NULL
Smal-Rsal	NULL
650	NULL
bp	NULL
fragment	NULL
,	NULL
consisting	NULL
of	NULL
the	NULL
3	NULL
'	NULL
323	NULL
bp	NULL
of	NULL
U3	NULL
,	NULL
complete	NULL
R	NULL
,	NULL
and	NULL
the	NULL
5	NULL
'	NULL
100	NULL
bp	NULL
of	NULL
US	NULL
,	NULL
derived	NULL
from	NULL
a	NULL
proviral	NULL
clone	NULL
pMT-2-15	NULL
(	NULL
13	NULL
,	NULL
and	NULL
H.	NULL
S.	NULL
unpublished	NULL
)	NULL
,	NULL
was	NULL
recloned	NULL
into	NULL
pUC19	NULL
using	NULL
synthetic	NULL
linkers	NULL
.	NULL

(	NULL
B	NULL
)	NULL
pMBG2	NULL
was	NULL
constructed	NULL
by	NULL
ligation	NULL
of	NULL
HindIII-BamHI	NULL
0.8	NULL
kb	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
B-globin	NULL
gene	NULL
pBR325-8G2	NULL
(	NULL
21	NULL
)	NULL
,	NULL
with	NULL
pUC18	NULL
.	NULL

(	NULL
C	NULL
)	NULL
pVHIOl	NULL
;	NULL
BglII-PstI	NULL
0.9	NULL
kb	NULL
fragment	NULL
of	NULL
rearranged	NULL
mouse	NULL
immunoglobulin	NULL
VH1Ol	NULL
gene	NULL
(	NULL
22	NULL
)	NULL
was	NULL
recloned	NULL
into	NULL
pUC19	NULL
.	NULL

(	NULL
D	NULL
)	NULL
pAd2	NULL
SmaI-F	NULL
was	NULL
described	NULL
elsewhere	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Coding	NULL
sequences	NULL
of	NULL
the	NULL
genes	NULL
are	NULL
represented	NULL
by	NULL
closed	NULL
boxes	NULL
,	NULL
noncoding	NULL
sequences	NULL
by	NULL
open	NULL
boxes	NULL
,	NULL
and	NULL
plasmid	NULL
sequences	NULL
by	NULL
lines	NULL
.	NULL

Only	NULL
relevant	NULL
restriction	NULL
sites	NULL
are	NULL
displayed	NULL
and	NULL
those	NULL
used	NULL
for	NULL
linearlization	NULL
are	NULL
shown	NULL
with	NULL
asterisks	NULL
.	NULL

The	NULL
initiation	NULL
sites	NULL
and	NULL
directions	NULL
of	NULL
transcription	NULL
are	NULL
indicated	NULL
by	NULL
closed	NULL
circles	NULL
and	NULL
arrows	NULL
,	NULL
respectively	NULL
.	NULL

initiation	NULL
of	NULL
transcription	NULL
.	NULL

To	NULL
study	NULL
specificity	NULL
of	NULL
transcription	NULL
reactions	NULL
catalyzed	NULL
by	NULL
various	NULL
cell	NULL
extracts	NULL
,	NULL
we	NULL
also	NULL
constructed	NULL
plasmids	NULL
containing	NULL
three	NULL
other	NULL
well-characterized	NULL
class	NULL
II	NULL
genes	NULL
;	NULL
the	NULL
major	NULL
late	NULL
gene	NULL
of	NULL
Adenovirus	NULL
2	NULL
(	NULL
Ad2ML	NULL
)	NULL
(	NULL
19	NULL
)	NULL
,	NULL
the	NULL
mouse	NULL
B-globin	NULL
gene	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
,	NULL
and	NULL
the	NULL
mouse	NULL
immunoglobulin	NULL
VH1Ol	NULL
gene	NULL
(	NULL
22	NULL
)	NULL
which	NULL
should	NULL
produce	NULL
transcripts	NULL
of	NULL
about	NULL
560	NULL
bases	NULL
,	NULL
470	NULL
bases	NULL
,	NULL
and	NULL
540	NULL
bases	NULL
,	NULL
respectively	NULL
,	NULL
when	NULL
cleaved	NULL
with	NULL
restriction	NULL
enzymes	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1.	NULL
pAd2	NULL
SmaI-F	NULL
was	NULL
digested	NULL
with	NULL
Smal	NULL
to	NULL
yield	NULL
two	NULL
separate	NULL
fragments	NULL
of	NULL
the	NULL
insert	NULL
and	NULL
vector	NULL
,	NULL
and	NULL
their	NULL
mixtures	NULL
were	NULL
used	NULL
as	NULL
a	NULL
template	NULL
.	NULL

All	NULL
the	NULL
other	NULL
plasmids	NULL
were	NULL
linearlized	NULL
by	NULL
digestion	NULL
with	NULL
restriction	NULL
enzymes	NULL
indicated	NULL
and	NULL
used	NULL
as	NULL
templates	NULL
.	NULL

Sizes	NULL
of	NULL
all	NULL
the	NULL
templates	NULL
are	NULL
about	NULL
the	NULL
same	NULL
.	NULL

Preferential	NULL
transcription	NULL
of	NULL
HTLV-I	NULL
LTR	NULL
in	NULL
MT-2	NULL
extracts	NULL
Optimal	NULL
amounts	NULL
of	NULL
different	NULL
template	NULL
DNA	NULL
were	NULL
approximately	NULL
equal	NULL
at	NULL
molar	NULL
basis	NULL
except	NULL
for	NULL
the	NULL
Ad2ML	NULL
promoter	NULL
most	NULL
active	NULL
at	NULL
a	NULL
one-third	NULL
4781	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
M	NULL
sume	NULL
-a	NULL
622	NULL
«	NULL
west	NULL
-as	NULL
527	NULL
-*	NULL
-=	NULL
309	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
in	NULL
HeLa	NULL
,	NULL
CESS	NULL
,	NULL
MT-1	NULL
or	NULL
MT-2	NULL
cell	NULL
extracts	NULL
.	NULL

RNAs	NULL
were	NULL
synthesized	NULL
in	NULL
the	NULL
conditions	NULL
containing	NULL
(	NULL
A	NULL
)	NULL
HeLa	NULL
,	NULL
(	NULL
B	NULL
)	NULL
CESS	NULL
,	NULL
(	NULL
C	NULL
)	NULL
MT-1	NULL
,	NULL
or	NULL
(	NULL
D	NULL
)	NULL
MT~2	NULL
cell	NULL
extract	NULL
.	NULL

Equal	NULL
amounts	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
of	NULL
truncated	NULL
DNAs	NULL
were	NULL
added	NULL
as	NULL
follows	NULL
;	NULL
lane	NULL
1	NULL
,	NULL
Smal-cleaved	NULL
pAd2	NULL
SmaI-F	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
BamHI-cleaved	NULL
pMBG2	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
HindIII-cleaved	NULL
pVH1O1	NULL
;	NULL
and	NULL
lane	NULL
4	NULL
,	NULL
HindIII-cleaved	NULL
pU3RU5S	NULL
.	NULL

Approximate	NULL
molar	NULL
ratios	NULL
of	NULL
pAd2	NULL
Smal-F	NULL
DNA	NULL
to	NULL
other	NULL
DNAs	NULL
were	NULL
0.3	NULL
.	NULL

Exposure	NULL
time	NULL
was	NULL
8	NULL
hr	NULL
for	NULL
(	NULL
A	NULL
)	NULL
,	NULL
(	NULL
B	NULL
)	NULL
and	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
36	NULL
hr	NULL
for	NULL
(	NULL
D	NULL
)	NULL
because	NULL
general	NULL
transcribing	NULL
activity	NULL
of	NULL
MT-2	NULL
extract	NULL
was	NULL
weaker	NULL
as	NULL
compared	NULL
with	NULL
other	NULL
cell	NULL
extracts	NULL
.	NULL

Lane	NULL
M	NULL
,	NULL
the	NULL
end-labeled	NULL
lipallI	NULL
digests	NULL
of	NULL
pBR32Z	NULL
as	NULL
size	NULL
marker	NULL
.	NULL

amount	NULL
of	NULL
the	NULL
other	NULL
templates	NULL
'	NULL
DNA	NULL
.	NULL

The	NULL
optimal	NULL
amount	NULL
of	NULL
each	NULL
template	NULL
was	NULL
tested	NULL
for	NULL
its	NULL
promoter	NULL
activity	NULL
in	NULL
extracts	NULL
of	NULL
HeLa	NULL
,	NULL
CESS	NULL
,	NULL
MT-l	NULL
or	NULL
MT-2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
Ad2ML	NULL
gene	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
$	NULL
-globin	NULL
gene	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
VH1Ol	NULL
gene	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
were	NULL
transcribed	NULL
in	NULL
all	NULL
the	NULL
extracts	NULL
with	NULL
relatively	NULL
comparable	NULL
efficiencies	NULL
.	NULL

All	NULL
the	NULL
three	NULL
templates	NULL
were	NULL
transcribed	NULL
less	NULL
efficiently	NULL
(	NULL
about	NULL
20	NULL
%	NULL
)	NULL
in	NULL
MT-2	NULL
extracts	NULL
than	NULL
in	NULL
CESS	NULL
,	NULL
HeLa	NULL
and	NULL
MT-1	NULL
extracts	NULL
.	NULL

However	NULL
,	NULL
the	NULL
distinct	NULL
run-off	NULL
products	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
promoter	NULL
were	NULL
produced	NULL
only	NULL
in	NULL
MT-2	NULL
extracts	NULL
.	NULL

Densitometer	NULL
tracing	NULL
of	NULL
the	NULL
330-base	NULL
band	NULL
showed	NULL
that	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
was	NULL
transcribed	NULL
in	NULL
MT-2	NULL
extract	NULL
at	NULL
least	NULL
five	NULL
times	NULL
more	NULL
efficiently	NULL
than	NULL
in	NULL
the	NULL
other	NULL
extracts	NULL
.	NULL

Consequently	NULL
,	NULL
when	NULL
the	NULL
amounts	NULL
of	NULL
transcripts	NULL
of	NULL
the	NULL
Ad2ML	NULL
,	NULL
$	NULL
-globin	NULL
,	NULL
VHLOl	NULL
genes	NULL
in	NULL
the	NULL
four	NULL
extracts	NULL
were	NULL
normalized	NULL
by	NULL
a	NULL
longer	NULL
exposure	NULL
of	NULL
transcripts	NULL
in	NULL
MT-2	NULL
extracts	NULL
,	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
was	NULL
transcribed	NULL
about	NULL
25	NULL
times	NULL
more	NULL
efficiently	NULL
than	NULL
in	NULL
the	NULL
other	NULL
three	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
4782	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Synthesis	NULL
of	NULL
all	NULL
the	NULL
transcripts	NULL
was	NULL
sensitive	NULL
to	NULL
«	NULL
-amanitin	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
obtained	NULL
similar	NULL
results	NULL
using	NULL
three	NULL
different	NULL
preparations	NULL
of	NULL
plasmid	NULL
DNA	NULL
and	NULL
cellular	NULL
extracts	NULL
.	NULL

Although	NULL
these	NULL
data	NULL
support	NULL
the	NULL
preferential	NULL
transcription	NULL
of	NULL
HTLV-I	NULL
LTR	NULL
in	NULL
MT-2	NULL
extracts	NULL
,	NULL
the	NULL
effect	NULL
might	NULL
be	NULL
due	NULL
to	NULL
different	NULL
stabilities	NULL
of	NULL
RNA	NULL
transcripts	NULL
in	NULL
various	NULL
extracts	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
synthesized	NULL
the	NULL
run-off	NULL
transcripts	NULL
of	NULL
LTR	NULL
and	NULL
VH1Ol	NULL
in	NULL
MT-2	NULL
extracts	NULL
.	NULL

The	NULL
purified	NULL
RNAs	NULL
were	NULL
incubated	NULL
with	NULL
Hela	NULL
,	NULL
CESS	NULL
,	NULL
MT-1	NULL
or	NULL
MT-2	NULL
extracts	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
RNAs	NULL
were	NULL
purified	NULL
again	NULL
and	NULL
analyzed	NULL
by	NULL
gel	NULL
electro-phoresis	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
the	NULL
two	NULL
transcripts	NULL
(	NULL
LTR	NULL
and	NULL
was	NULL
constant	NULL
in	NULL
all	NULL
the	NULL
reactions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
MT-2	NULL
extracts	NULL
do	NULL
not	NULL
preferentially	NULL
stabilize	NULL
LTR	NULL
transcripts	NULL
.	NULL

We	NULL
conclude	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
MT-2	NULL
extracts	NULL
,	NULL
compared	NULL
to	NULL
the	NULL
other	NULL
cellular	NULL
extracts	NULL
,	NULL
preferentially	NULL
transcribe	NULL
the	NULL
LTR	NULL
of	NULL
HTLV-I	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
MT-2	NULL
extracts	NULL
contain	NULL
a	NULL
soluble	NULL
trans-acting	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
that	NULL
stimulates	NULL
preferential	NULL
transcription	NULL
of	NULL
HTLV-I	NULL
LTR	NULL
.	NULL

These	NULL
observations	NULL
correlate	NULL
well	NULL
with	NULL
the	NULL
previous	NULL
in	NULL
vivo	NULL
experiments	NULL
reported	NULL
by	NULL
several	NULL
groups	NULL
(	NULL
6	NULL
,	NULL
10-12	NULL
)	NULL
that	NULL
the	NULL
fusion	NULL
gene	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
and	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
was	NULL
expressed	NULL
markedly	NULL
more	NULL
strongly	NULL
in	NULL
HTLV-I-infected	NULL
cells	NULL
expressing	NULL
viral	NULL
proteins	NULL
such	NULL
as	NULL
MT-2	NULL
than	NULL
in	NULL
HTLV-I-uninfected	NULL
or	NULL
infected	NULL
cells	NULL
expressing	NULL
little	NULL
viral	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
HeLa	NULL
,	NULL
CESS	NULL
and	NULL
MT-1	NULL
.	NULL

They	NULL
proposed	NULL
that	NULL
the	NULL
pX-encoded	NULL
protein	NULL
(	NULL
p40x	NULL
or	NULL
tat	NULL
)	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
trans-activation	NULL
of	NULL
LTR	NULL
in	NULL
HTLV-I-infected	NULL
cells	NULL
.	NULL

To	NULL
see	NULL
whether	NULL
trans-acting	NULL
molecules	NULL
in	NULL
MT-2	NULL
extracts	NULL
are	NULL
also	NULL
active	NULL
in	NULL
HeLa	NULL
extracts	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
in	NULL
vitro	NULL
transcription	NULL
of	NULL
LTR	NULL
in	NULL
a	NULL
mixture	NULL
of	NULL
HeLa	NULL
and	NULL
MT-2	NULL
extracts	NULL
with	NULL
various	NULL
ratios	NULL
.	NULL

Although	NULL
transcription	NULL
of	NULL
.	NULL

LTR	NULL
in	NULL
Hela	NULL
extracts	NULL
was	NULL
weak	NULL
(	NULL
23	NULL
%	NULL
of	NULL
MT-2	NULL
extracts	NULL
)	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
small	NULL
portion	NULL
(	NULL
17	NULL
%	NULL
)	NULL
of	NULL
MT-2	NULL
extracts	NULL
enhanced	NULL
synthesis	NULL
of	NULL
LTR	NULL
transcripts	NULL
greatly	NULL
(	NULL
61	NULL
%	NULL
of	NULL
MI-2	NULL
extracts	NULL
)	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
extents	NULL
of	NULL
stimulation	NULL
were	NULL
always	NULL
significantly	NULL
greater	NULL
than	NULL
the	NULL
expected	NULL
activities	NULL
calculated	NULL
by	NULL
a	NULL
direct	NULL
contribution	NULL
of	NULL
MT-2	NULL
extracts	NULL
added	NULL
to	NULL
HeLa	NULL
extracts	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

LTR	NULL
was	NULL
transcribed	NULL
in	NULL
83	NULL
%	NULL
MT-2	NULL
extracts	NULL
even	NULL
more	NULL
efficiently	NULL
than	NULL
in	NULL
100	NULL
%	NULL
MT-2	NULL
extracts	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
trans-acting	NULL
molecules	NULL
in	NULL
MT-2	NULL
coordinated	NULL
with	NULL
the	NULL
stronger	NULL
trans-	NULL
,	NULL
criptional	NULL
machinery	NULL
of	NULL
HeLa	NULL
cells	NULL
for	NULL
preferential	NULL
expression	NULL
of	NULL
the	NULL
LTR	NULL
promoter	NULL
and	NULL
that	NULL
the	NULL
trans-acting	NULL
molecule	NULL
(	NULL
s	NULL
)	NULL
is	NULL
limiting	NULL
for	NULL
LTR	NULL
expres-	NULL
sion	NULL
in	NULL
HeLa	NULL
extracts	NULL
.	NULL

4783	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
G6	NULL
T7	NULL
MT-2	NULL
(	NULL
%	NULL
)	NULL
0	NULL
17	NULL
33	NULL
50	NULL
67	NULL
83	NULL
100	NULL
Ph	NULL
|	NULL
<	NULL
VH101	NULL
«	NULL
LTR	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Transcribing	NULL
activities	NULL
in	NULL
mixtures	NULL
of	NULL
HeLa	NULL
and	NULL
MT-2	NULL
extracts	NULL
.	NULL

Equal	NULL
amounts	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
of	NULL
HindIII-cleaved	NULL
pVH1Ol	NULL
(	NULL
A	NULL
)	NULL
or	NULL
HindIII-cleaved	NULL
pU3RUS	NULL
(	NULL
B	NULL
)	NULL
was	NULL
transcribed	NULL
in	NULL
either	NULL
HeLa	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
MT-2	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
mixtures	NULL
of	NULL
both	NULL
extracts	NULL
at	NULL
indicated	NULL
ratios	NULL
(	NULL
lane	NULL
2-7	NULL
)	NULL
.	NULL

Exposure	NULL
time	NULL
was	NULL
8	NULL
hr	NULL
for	NULL
(	NULL
A	NULL
)	NULL
and	NULL
24	NULL
hr	NULL
for	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Table	NULL
1	NULL
.	NULL

Transcription	NULL
of	NULL
LTR	NULL
and	NULL
VH1Ol	NULL
promoters	NULL
in	NULL
mixtures	NULL
of	NULL
Hela	NULL
and	NULL
MT-2	NULL
extracts	NULL
VH1LOL	NULL
gene	NULL
LTR	NULL
Lanes	NULL
MT-2	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
extracts	NULL
(	NULL
%	NULL
)	NULL
calculated	NULL
experiments|	NULL
calculated	NULL
experiments|	NULL
1	NULL
0	NULL
100	NULL
100	NULL
23	NULL
23	NULL
2	NULL
17	NULL
86	NULL
98	NULL
36	NULL
61	NULL
3	NULL
33	NULL
72	NULL
75	NULL
49	NULL
61	NULL
4	NULL
50	NULL
59	NULL
63	NULL
62	NULL
90	NULL
5	NULL
67	NULL
45	NULL
52	NULL
75	NULL
99	NULL
6	NULL
83	NULL
31	NULL
51	NULL
87	NULL
132	NULL
7	NULL
100	NULL
17	NULL
17	NULL
100	NULL
100	NULL
Calculated	NULL
activities	NULL
were	NULL
estimated	NULL
assuming	NULL
that	NULL
activities	NULL
of	NULL
mixed	NULL
extracts	NULL
are	NULL
proportional	NULL
to	NULL
the	NULL
amounts	NULL
of	NULL
HeLa	NULL
and	NULL
MT-2	NULL
extracts	NULL
added	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
HeLa	NULL
and	NULL
MT-2	NULL
extracts	NULL
are	NULL
taken	NULL
from	NULL
the	NULL
values	NULL
in	NULL
lanes	NULL
1	NULL
and	NULL
7	NULL
.	NULL

Experimental	NULL
activities	NULL
were	NULL
determined	NULL
by	NULL
densitometry	NULL
tracing	NULL
of	NULL
the	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Numbers	NULL
are	NULL
percentages	NULL
of	NULL
positive	NULL
control	NULL
(	NULL
100	NULL
%	NULL
HeLa	NULL
extracts	NULL
for	NULL
VH1Ol	NULL
gene	NULL
and	NULL
100	NULL
%	NULL
MT-2	NULL
extracts	NULL
for	NULL
LTR	NULL
)	NULL
.	NULL

4784	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
In	NULL
contrast	NULL
,	NULL
transcription	NULL
of	NULL
the	NULL
immunoglobulin	NULL
VHLIOl	NULL
gene	NULL
in	NULL
Hela	NULL
cell	NULL
extracts	NULL
produced	NULL
the	NULL
distinct	NULL
run-off	NULL
transcripts	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
which	NULL
decreased	NULL
gradually	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
MT-2	NULL
extracts	NULL
to	NULL
HeLa	NULL
cell	NULL
extracts	NULL
was	NULL
increased	NULL
(	NULL
lane	NULL
2-7	NULL
)	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
general	NULL
transcribing	NULL
activity	NULL
of	NULL
MT-2	NULL
extracts	NULL
was	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
Hela	NULL
cell	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
the	NULL
VHIOl	NULL
gene	NULL
products	NULL
were	NULL
in	NULL
general	NULL
agreement	NULL
with	NULL
the	NULL
expected	NULL
activity	NULL
calculated	NULL
from	NULL
the	NULL
por-	NULL
tions	NULL
of	NULL
the	NULL
two	NULL
extracts	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

These	NULL
data	NULL
strongly	NULL
suggest	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
specific	NULL
trans-acting	NULL
factor	NULL
in	NULL
MT-2	NULL
extracts	NULL
and	NULL
its	NULL
involvement	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
.	NULL

It	NULL
is	NULL
difficult	NULL
to	NULL
discriminate	NULL
whether	NULL
the	NULL
LTR	NULL
activation	NULL
was	NULL
due	NULL
to	NULL
the	NULL
direct	NULL
enhancement	NULL
of	NULL
transcription	NULL
or	NULL
the	NULL
in-activation	NULL
of	NULL
a	NULL
repressor	NULL
molecule	NULL
.	NULL

We	NULL
do	NULL
not	NULL
know	NULL
whether	NULL
this	NULL
factor	NULL
is	NULL
the	NULL
product	NULL
of	NULL
the	NULL
pX	NULL
sequence	NULL
per	NULL
se	NULL
or	NULL
a	NULL
cellular	NULL
component	NULL
modified	NULL
by	NULL
the	NULL
pX	NULL
product	NULL
.	NULL

Our	NULL
cell-free	NULL
system	NULL
will	NULL
provide	NULL
a	NULL
clue	NULL
to	NULL
purify	NULL
this	NULL
factor	NULL
and	NULL
to	NULL
study	NULL
the	NULL
molecular	NULL
mechanism	NULL
of	NULL
the	NULL
trans-activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
transcription	NULL
.	NULL

ACKNOWLEDGEMENT	NULL
We	NULL
thank	NULL
Ms.	NULL
Y.	NULL
Utsunomiya	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

Ms.	NULL
K.	NULL
Hirano	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
investigation	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
and	NULL
Cul-	NULL
ture	NULL
of	NULL
Japan	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Uchiyama	NULL
,	NULL
T.	NULL
,	NULL
Yodoi	NULL
,	NULL
J.	NULL
,	NULL
Sagawa	NULL
,	NULL
K.	NULL
,	NULL
Takatsuki	NULL
,	NULL
K.	NULL
&	NULL
Uchino	NULL
,	NULL
H.	NULL
(	NULL
1977	NULL
)	NULL
Blood	NULL
50	NULL
,	NULL
481-492	NULL
.	NULL

2	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Ruscetti	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Gazdar	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Bunn	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Minna	NULL
,	NULL
J.	NULL
D.	NULL
&	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1980	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77	NULL
,	NULL
7415-7419	NULL
.	NULL

3	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Miyoshi	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79	NULL
,	NULL
2031-2035	NULL
.	NULL

4	NULL
.	NULL

Seiki	NULL
,	NULL
M.	NULL
,	NULL
Hattori	NULL
,	NULL
S.	NULL
,	NULL
Hirayama	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80	NULL
,	NULL
3618-3622	NULL
.	NULL

5	NULL
.	NULL

Haseltine	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
Sodroski	NULL
,	NULL
J.	NULL
,	NULL
Patarca	NULL
,	NULL
R.	NULL
,	NULL
Briggs	NULL
,	NULL
D.	NULL
,	NULL
Perkins	NULL
,	NULL
D.	NULL
&	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
(	NULL
1984	NULL
)	NULL
Science	NULL
225	NULL
,	NULL
419-421	NULL
.	NULL

6	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

&	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Science	NULL
225	NULL
,	NULL
381-385	NULL
.	NULL

7	NULL
.	NULL

Chen	NULL
,	NULL
I.	NULL
S.	NULL
Y.	NULL
,	NULL
McLaughlin	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Golde	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
Nature	NULL
309	NULL
,	NULL
276-279	NULL
.	NULL

8	NULL
.	NULL

Derse	NULL
,	NULL
D.	NULL
,	NULL
Caradonna	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

&	NULL
Casey	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
227	NULL
,	NULL
317-320	NULL
.	NULL

9	NULL
.	NULL

Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Kettman	NULL
,	NULL
R.	NULL
,	NULL
Burny	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Science	NULL
227	NULL
,	NULL
320-322	NULL
.	NULL

10	NULL
.	NULL

Fujisawa	NULL
,	NULL
J.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Kiyokawa	NULL
,	NULL
T.	NULL
&	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82	NULL
,	NULL
2277-2281	NULL
.	NULL

4785	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
,	NULL
Goh	NULL
,	NULL
W.	NULL
C.	NULL
&	NULL
Haseltine	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
228	NULL
,	NULL
1430-1434	NULL
.	NULL

Felber	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Paskalis	NULL
,	NULL
H.	NULL
,	NULL
Kleinman-Ewing	NULL
,	NULL
C.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
&	NULL
Pavlakis	NULL
,	NULL
G.	NULL
N.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
229	NULL
,	NULL
675-679	NULL
.	NULL

Kobayashi	NULL
,	NULL
N.	NULL
,	NULL
Konishi	NULL
,	NULL
H.	NULL
,	NULL
Sabe	NULL
,	NULL
H.	NULL
,	NULL
Shigesada	NULL
,	NULL
K.	NULL
,	NULL
Noma	NULL
,	NULL
T.	NULL
,	NULL
Honjo	NULL
,	NULL
T.	NULL
&	NULL
Hatanaka	NULL
,	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

3	NULL
,	NULL
1339-1343	NULL
.	NULL

Muraguchi	NULL
,	NULL
A.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
Miki	NULL
,	NULL
Y.	NULL
,	NULL
Kuritani	NULL
,	NULL
T.	NULL
,	NULL
Kaieda	NULL
,	NULL
T.	NULL
,	NULL
Yoshizaki	NULL
,	NULL
K.	NULL
,	NULL
&	NULL
Yamamura	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

127	NULL
,	NULL
412-416	NULL
.	NULL

Miyoshi	NULL
,	NULL
I.	NULL
,	NULL
Kubonishi	NULL
,	NULL
I.	NULL
,	NULL
Sumida	NULL
,	NULL
M.	NULL
,	NULL
Hiraki	NULL
,	NULL
S.	NULL
,	NULL
Tsubota	NULL
,	NULL
T.	NULL
,	NULL
Kimura	NULL
,	NULL
I.	NULL
,	NULL
Miyamoto	NULL
,	NULL
K.	NULL
&	NULL
Sato	NULL
J	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
Gann	NULL
71	NULL
,	NULL
155-156	NULL
.	NULL

Miyoshi	NULL
,	NULL
I.	NULL
,	NULL
Kubonishi	NULL
,	NULL
I.	NULL
,	NULL
Yoshimoto	NULL
,	NULL
S.	NULL
,	NULL
Akagi	NULL
,	NULL
T.	NULL
,	NULL
Ohtsuki	NULL
,	NULL
Y.	NULL
,	NULL
Shiraishi	NULL
,	NULL
Y.	NULL
,	NULL
Nagata	NULL
,	NULL
K.	NULL
&	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Nature	NULL
294	NULL
,	NULL
770-771	NULL
.	NULL

Manley	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Fire	NULL
,	NULL
A.	NULL
,	NULL
Cano	NULL
,	NULL
A.	NULL
,	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Gefter	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1980	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77	NULL
,	NULL
3855-3859	NULL
.	NULL

Parker	NULL
,	NULL
C.	NULL
P.	NULL
&	NULL
Topol	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Cell	NULL
37	NULL
,	NULL
273-283	NULL
.	NULL

Weil	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Luse	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Segall	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1979	NULL
)	NULL
Cell	NULL
18	NULL
,	NULL
469-484	NULL
.	NULL

Luse	NULL
,	NULL
D.	NULL
S.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1980	NULL
)	NULL
Cell	NULL
20	NULL
,	NULL
691-699	NULL
.	NULL

Tsuda	NULL
,	NULL
M.	NULL
&	NULL
Suzuki	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Cell	NULL
27	NULL
,	NULL
175-182	NULL
.	NULL

Kataoka	NULL
,	NULL
T.	NULL
,	NULL
Nikaido	NULL
,	NULL
T.	NULL
,	NULL
Miyata	NULL
,	NULL
T.	NULL
,	NULL
Moriwaki	NULL
,	NULL
K.	NULL
&	NULL
Honjo	NULL
,	NULL
T.	NULL
(	NULL
1982	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

257	NULL
,	NULL
277-285	NULL
.	NULL

4786	NULL

